There is an urgent need for an effective vaccine against human disease caused by B. 29 pseudomallei, and although a wide range of candidates have been tested in mice none 30 provide high level protection. We considered this might reflect the inability of these vaccine 31 candidates to protect against chronic disease. Using Q-RT PCR we have identified 6 genes 32 which are expressed in bacteria colonising spleens and lungs of chronically infected mice. 33
template but without the RT step. B. pseudomallei housekeeping genes BPSL2188 (aceA) 167 and BPSL3159 (gltB) were used as internal controls for expression profiling. Both BPSL2188 168 and BPSL3159 were selected as controls as neither of the genes was found to be 169 differentially regulated in vivo in mice compared to broth culture (data not presented). In a 170 reaction volume of 50μl, 25μl of 2 X QuantiTect SYBR Green RT-PCR master mix, 0.5 μM of 171 forward and reverse primers, 0.5μl QuantiTect RT mix, <500ng template RNA, RNase-free 172 water was added to make the reaction volume to 50 μl. PCR reaction conditions were; 50°C 173 for 30 minutes for reverse transcription, followed by a PCR initial activation step of 95°C for 174 15 minutes. Four step cycling of 94°C for 15 seconds (denaturation), 50°C for 30 seconds 175 (annealing), 72°C for 30 seconds (extension) and 40°C for 15 seconds (40 cycles). 176
Reactions were performed using a Stratagene Mx3005P Q-PCR system. Ct values were 177 calculated for all samples. Relative expression levels were calculated using 2 -ΔΔct analysis. 178 179
Antigen production 180
Genes encoding for BPSL1897 (residues 40 to 155), BPSL3369 (residues 1 to 506) and 181 BPSL2287 (residues 1 to 107) were purchased as codon-optimised synthetic genes 182 (GenScript). To facilitate subsequent cloning by digestion and ligation into pGEX4T-1 (Life 183 Bacterial cells from a 0.5 L culture were harvested and lysed in PBS using a cell disruption 191 system at 25mPa (Constant Systems Limited). Following centrifugation at 18,000 rpm and 192 addition of 50 g/l deoxyribonucleases (Sigma-Aldrich) and 10 mM magnesium chloride,the soluble fraction was loaded onto a 5 ml GSTrap FF column (BPSL2287) or 5 ml 194
Glutathione Sepharose 4B resin (GE healthcare) in a gravity-flow setup (BPSL3369), pre-195 equilibrated with PBS containing 10 % glycerol and 5 mM dithiothreitol (DTT). A final wash 196 was carried out with PBS to remove DTT and glycerol prior to cleavage with 20U 197 (BPSL3369) or 40U (BPSL2287) thrombin (Sigma-Aldrich). Tag cleavage was carried out in 198 PBS, incubating overnight at 20C (with gentle rotation for batch purifications). Thrombin 199 was removed from the cleaved protein solutions using a 1 ml HiTrap Benzamidine FF 200 column (GE Healthcare), pre-equilibrated in PBS containing 1M NaCl. Proteins were 201 exchanged into PBS using a PD10 desalting column (GE Healthcare) and concentrated to 202 1mg/ml using Amicon Ultra-15 Centrifugal Filter Units (Millipore) with an appropriate MW cut-203 off. Recombinant BPSL2765 was produced as a N-terminal histidine-tagged protein as 204 previously described (Gourlay et al, 2013) . were harvested and mechanically lysed in PBS, and fractionated as described above. 208
Following DNAse treatment, the supernatant was loaded onto a 5 ml Bio-Scale Mini Profinia 209 IMAC cartridge (Bio-rad) and exchanged into PBS using a 50ml Mini-Scale Bio-Gel P6 210
Desalting cartridge using the Profinia Protein Purification System, according to standard Bio-211 rad protocols. BPSL1899 were transcribed at higher levels than one or both housekeeping genes aceA 296 and gltB in both lungs and spleens of chronically infected mice (Table 3 ). B. pseudomallei 297 genes BPSL3312, BPSL2289 and BPSS0369 were transcribed at a lower level than 298 housekeeping genes in lungs and spleens of chronically infected mice. Therefore, of the nine 299 genes identified from in vitro transcriptome analysis, six, BPSL0296, BPSL1897, BPSL1899, 300 BPSL2287, BPSL3247 and BPSL3369, were found to be expressed at levels higher than 301 housekeeping genes by B. pseudomallei during chronic infection. These genes were 302 therefore selected for over-expression of the encoded proteins. 303 304
Over-expression and purification of proteins
Of the 6 genes we identified that were highly expressed during chronic infection, we were 306 able to overexpress and purify three of the encoded proteins (BPSL1897, BPSL2287 and 307 BPSL3369). Two of the proteins (BPSL0296 and BPSL3247) were insoluble when 308 expressed in E. coli and we could not detect expression of BPSL1899. tested BPSL1897, 309 BPSL2287 and BPSL3369 were expressed as N-terminal GST-tagged fusion proteins, and 310 purified as described in the Materials and Methods section. Yields ranged from 2 to 5 mg per 311 litre of bacterial culture (Table 4) . Following removal of the GST-tag, BPSL3369 migrated 312 with a MW in line with the theoretical value of 55.6 kDa (Fig. 1 ). There were diverse bands 313 visible for BPSL2287 at approx. 12 kDa, 14 kDa, 26 kDa, 28 kDa, and a faint band at 40 kDa 314 (Fig. 1) . As BPSL2287 contains three cysteine residues in the conserved CX n CGCG motif 315 shared by HesB family members it is likely that the 12 kDa and 14 kDa bands correspond to 316 diversely compacted forms of the protein monomer, whereas the 26 kDa and 28 kDa bands judged to be >95% pure (Table 2) . LolC was purified (approx. 20 mg protein/L culture; > 90% 331 pure) as a C-terminal His-tag, as described in the Materials and Methods section, andmigrated with a MW of 26k Da, in agreement with its theoretical MW of 26.4 kDa (Fig. 1) . 333
Protein purity for all antigens was judged by SDS-PAGE and ranged from 90-95 % (Table 4) . 334 335
ELISA 336
Mice were immunised with a combination of BPSL2765, BPSL3369, BPSL2287 and 337 BPSL1897 as described above. The immunised mice were tail-bled two weeks after the final 338 boost and levels of serum antibodies were assessed using an ELISA ( Table 5 protective vaccine candidates identified to date [32] . The challenged mice were observed 356 until 49 days post infection (Fig 2) . 
